About Us  Corporate Profile |
| |
| Corporate Profile |
 |
| Wanbury Limited the fastest growing pharma company amongst top 100 companies in India as per ORG-IMS has strong presence in domestic branded formulations. Wanbury’s major thrust area also lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006. |
| |
| |
| |
 |
| |
| |
| Formulations : |
|
| |
 Fastest growing company amongst top 100 companies in the domestic market as per ORG IMS. |
| Ranks 47th as per ORG-IMS (Jan-2009) |
| Has three divisions namely Main division, Osteolife and Surglife. |
| Strong presence in Gynaecology, Orthopedics, Surgery and Gastro-intestinal. |
| Cpink, one of the key brands of Wanbury was awarded "Best Brand Launch" by ORG-IMS in India in 06-07. |
| Rabiplus, another key brand of Wanbury, was awarded “Best Brand Launch” by ORG-IMS in India in 07-08. |
| Cpink, Rabiplus, Folinine and Adtrol Plus are among the ‘Top 4’ brands in their respective segments |
| |
| API : |
|
| |
| World’s largest manufacturer of Metformin. |
| Largest US market share in Tramadol and Salsalate, besides Metformin. |
| Over 27 DMFs (Drug Master Files) filed. |
| 2 approved product patents. 5 product patents and 1 process patent applied. |
| Over 17 actively marketed products including Clopidogrel, Levetiracetam, Telmisartan, Carvedilol, Sertraline, Losartan etc. |
| Exports to over 50 countries, 65% of which is to the regulated markets. |
| 3 API manufacturing facilities including 2 US FDA approved multi-product API facilities for regulated markets. |
| |
| Next |
| |
| |
